Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kirkpatrick Lynn
Relationship:   Chief Executive Office...
City:   Tucson
State:   AZ
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   1,182,090    

Indirect Shares

  813,633      
Direct Value   $216,089    

Indirect Value

  $0      
Total Shares   1,995,723      
Total Value   $216,089      


Cascadian Therapeutics, Inc
 $0 Ensysce Biosciences Ord Shs
 $216,089 Cascadian Therapeutics, Inc
 $0 Ensysce Biosciences Ord Shs
 $216,089
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cascadian Therapeutics, Inc CASC Chief Scientific Officer 2007-12-10 800,239 2007-12-10 813,633    Premium*  
            Ensysce Biosciences Ord Shs ENSC Chief Executive Office... 2022-05-26 381,851 2021-06-30 0    Premium*  
* Premium Members only  

Records found :    5         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ENSC Ensysce Biosciences Ord S... Chief Executive Officer   •       •      –    2022-05-26 4 B $0.53 $14,216 D/D 27,000 381,851 2.81 -
ENSC Ensysce Biosciences Ord S... Chief Executive Officer   •       •      –    2022-05-25 4 B $0.49 $34,083 D/D 70,000 354,851 2.81 -
ENSC Ensysce Biosciences Ord S... Chief Executive Officer   •       •      –    2021-06-30 4 A $0.00 $0 D/D 284,851 284,851 0 -
CASC Cascadian Therapeutics, I... Chief Scientific Officer   •       –      –    2007-12-10 4 A $0.00 $0 D/D 800,239 800,239 0 -
CASC Cascadian Therapeutics, I... Chief Scientific Officer   •       –      –    2007-12-10 4 A $0.00 $0 I/I 813,633 813,633 0 -

  5  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed